Abstract
To estimate the prevalence of hepatitis B virus (HBV), tetanus, hepatitis A virus (HAV) and human immunodeficiency virus (HIV) in injecting drug users (IDUs), risk factors associated with infection and the feasibility of HBV vaccine delivery in HBV seronegatives. Cross-sectional seroprevalence survey of 1535 IDUs recruited from 17 Bangkok Metropolitan Administration (BMA) methadone clinics and HBV vaccination of seronegatives. Prevalence of antibody to HBV, tetanus, HAV and HIV was 87.8%, 68.1%, 60.2% and 35.9%, respectively. Prevalence of HBV and HAV increased with increasing age; prevalence of tetanus decreased with increasing age. Being HIV seropositive was related inversely to income and being tetanus seronegative. Of the 189 HBV seronegative IDUs, 81.0% completed the vaccine series. IDUs with HIV had a 6.5-fold odds of vaccine non-response. These data underscore the need for, and feasibility of, vaccine delivery in this population and support targeting efforts at high-risk age groups.
References
Jan 1, 1992·Vaccine·J M RodrigoA Artero
Jan 1, 1992·Journal of Clinical Gastroenterology·M BrugueraJ Sans
Apr 1, 1991·The Journal of Infectious Diseases·P MezzelaniD C Des Jarlais
Mar 1, 1991·Archives of Internal Medicine·M RumiP M Mannucci
Sep 4, 1989·The American Journal of Medicine·F E André
Jul 1, 1986·The Journal of Infection·B A ZajacE M Scolnick
Jul 15, 1988·Annals of Internal Medicine·A C CollierH H Handsfield
Aug 1, 1995·American Journal of Epidemiology·O S LevineK E Nelson
Apr 1, 1994·AIDS·S C Tayal, K N Sankar
May 1, 1996·American Journal of Public Health·R S GarfeinK E Nelson
Nov 1, 1996·International Journal of STD & AIDS·E K WongB Donovan
Jun 1, 1997·Vaccine·F LugoboniP Mezzelani
Feb 3, 1998·International Journal of Epidemiology·K StarkI Guggenmoos-Holzmann
Dec 22, 1999·Addiction·L BorgM J Kreek
Jan 29, 2000·Vaccine·D ReyJ M Lang
Dec 15, 2000·Vaccine·Y PoovorawanS Chunsuttiwat
Mar 29, 2001·AIDS·S VanichseniK Choopanya
Oct 31, 2001·American Journal of Public Health·D C Des JarlaisD Perlman
Jan 29, 2002·Epidemiology and Infection·D O'DonovanK Stene-Johansen
Feb 28, 2002·American Journal of Public Health·Christopher S MurrillMarta Gwinn
May 30, 2003·American Journal of Public Health·Paula J LumUNKNOWN UFO Study
Mar 20, 2004·The Journal of Infectious Diseases·Gregory J DoreUNKNOWN 907 Study Team
Feb 20, 2007·Journal of Viral Hepatitis·M K JainW M Lee
May 18, 2007·Drug and Alcohol Dependence·Wantanee WattanaWilliam C Levine
Jun 15, 2007·HIV Medicine·M K OsbornD Rimland
Citations
Jul 6, 2014·BMC Public Health·Yung-Feng YenChung-Yeh Deng
Sep 9, 2010·Expert Review of Vaccines·Berma M KinseyFrank M Orson
Dec 15, 2010·The International Journal on Drug Policy·Abdul NasirJeffrey Tjaden
Jul 21, 2010·Addiction·M Patrizia CarrieriLaurent Michel
Jun 4, 2020·Pathogens·Roya RashtiGhobad Moradi
Dec 2, 2021·PloS One·Gustavo Hernandez-SuarezYong Poovorawan